Suchergebnisse - "Kazama, Itsuro"

PubPharm (56)

1

Brain Leukocytes as the Potential Therapeutic Target for Post-COVID-19 Brain Fog

enthalten in: Neurochemical research | 2023

von Kazama, I.

2

Targeting ACE2 as a potential prophylactic strategy against COVID-19-induced exacerbation of chronic kidney disease

enthalten in: Inflammation research | 2022

von Kazama, I.

3

Effects of indacaterol on the LPS-evoked changes in fluid secretion rate and pH in swine tracheal membrane

enthalten in: Pflügers Archiv | 2021

von Aritake, H. | Tamada, T. | Murakami, K. | +5

4

High-calcium exposure to frog heart: a simple model representing hypercalcemia-induced ECG abnormalities

enthalten in: The Journal of veterinary medical science | 2017

von KAZAMA, I.

5

Less contribution of mast cells to the progression of renal fibrosis in Rat kidneys with chronic renal failure

enthalten in: Nephrology | 2017

von Baba, A. | Tachi, M. | Ejima, Y. | +7

6

Hydrocortisone and dexamethasone dose-dependently stabilize mast cells derived from rat peritoneum

enthalten in: Pharmacological reports | 2016

von Mori, T. | Abe, N. | Saito, K. | +7

7

Lymphocyte Kv1.3-channels in the pathogenesis of chronic obstructive pulmonary disease : novel therapeutic implications of targeting the channels by commonly used drugs

enthalten in: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology | 2016

von Kazama, I. | Tamada, T.

8

Burn-induced subepicardial injury in frog heart: a simple model mimicking ST segment changes in ischemic heart disease

enthalten in: The Journal of veterinary medical science | 2016

von Kazama, I.

9

Clarithromycin Dose-Dependently Stabilizes Rat Peritoneal Mast Cells

enthalten in: Chemotherapy | 2016

von Kazama, I. | Saito, K. | Baba, A. | +7

10

Usefulness of targeting lymphocyte Kv1.3-channels in the treatment of respiratory diseases

enthalten in: Inflammation research | 2015

von Kazama, I. | Tamada, T. | Tachi, M.

1
2
3
4
5
6
Nächster »
[6]